Bollywood – India’s $10 billion (£4.8 billion) film industry – is growing fast. Indian cinemas sold nearly four billion tickets last year. The number of multiplex screens is expected to double to more than 3,000 in the next two years. And it is not only cinema audiences that are growing strongly in India; the home entertainment sector is too. Revenues in this market have doubled in a year and the number of pay-TV households is expected to double by 2011. Meanwhile, demand for Bollywood productions around the rest of the globe has never been stronger.
One company riding this growth wave is Eros International, an integrated entertainment and media business that spans production and commissioning of films with worldwide distribution. If you have rented an Indian DVD in Britain, there is a good chance Eros had a hand in it. The business has been going for 30 years and is now playing a lead role in consolidating the fragmented market in India.
Last week it produced interim figures for the six months to the end of September. Reporting in US dollars, Eros said turnover had jumped 59 per cent (to $34.6 million) and profit by 76 per cent to $13.6 million pre-tax. Earnings were up from 7.4 cents a share to 11.5 and cash flow had risen by nearly 40 per cent to $15.4 million. If the progress is maintained in the second half of the year, Eros will produce earnings of around 55 cents – or about 26p a share. That would leave the shares, which have come back from a year’s high of close to 600p to 400p, selling for just over 15 times earnings. For such a growth stock, that is cheap.
Eros, with a market cap of more than £450 million, is by no means a small company. It has seen its share of the Indian film market rise from 32 per cent between 1998 and 2007 to 47 per cent in the first ten months of this year. In the six-month period, Eros released 11 films, eight of them globally. There is a lot happening in TV syndication, not only in India but also across South East Asia, and the company has struck new distribution deals in Europe, too. In the new media area, Eros concluded new deals with Sky Anytime, Joost, NME, Vudu, Mauritius Telecom and Singnet during the period.
One indicator of Eros’s potential is the fact that in September, at the height of the international credit crunch, it got Citigroup Global Markets to underwrite a $100 million, five-year acquisition financing facility. That looks a major vote of confidence. After the pullback in the shares, investors have another chance to climb aboard what is a global entertainment force in the making. We think Eros is one to pick up and lock away.
More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.
Advertisement
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.
Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.
London pub operator The Capital Pub Company is seeing continuing sales growth on the back of a surprisingly resilient market.